Leonardo Roever: Progress in Prevention, Treatment, and National Care Strategies for Stroke in China
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article by Simiao Wu et al, published in The Lancet Neurology, adding:
”Stroke in China: Advances in Prevention and Treatment Towards a Healthy China
Stroke incidence and mortality have decreased in China over the past decade; however, stroke prevalence continues to rise due to the aging population.
In line with the ‘Healthy China 2030’ plan, there has been a strategic reorientation of health services towards the prevention of serious diseases, including stroke.
Along with the establishment of a national network of stroke centers to enhance stroke care and research, there has also been progress in understanding stroke etiology, screening and controlling risk factors, and promoting early diagnosis and treatment.
Evidence from high-quality randomized clinical trials in China supports the widespread adoption of reperfusion therapies for ischemic stroke, early reduction of blood pressure after intracerebral hemorrhage, individualized approaches to secondary prevention, and evaluation of research on neuroprotective agents.
Future efforts should focus on promoting a healthy lifestyle, public education on stroke prevention and timely access to stroke services, training healthcare professionals working in stroke care in evidence-based care, and improving pre- and post-hospital stroke services.”
Title: Stroke in China: advances in prevention and management on the path to a healthy China
Authors: Simiao Wu, Yanan Wang, Junfeng Liu, Craig Anderson, Zhengming Chen, Peter Sandercock, Thanh Nguyen, Xunming Ji, Yongjun Wang, Jinsheng Zeng, Bin Peng, Xinfeng Liu, Zhouping Tang, Qingwu Yang, Yun Xu, Bo Wu, Ming Liu on behalf of the China Stroke Study Collaboration
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 3, 2026, 17:24N. Mariana S. Vasquez: JAK2 Mutations The High-Yield Map of Myeloproliferative Neoplasms
-
Sep 3, 2026, 17:08Khusi Dhara: Why Women Need to Pay Attention to Iron
-
Sep 3, 2026, 16:54Ralf LudwigÖ‰ Testing Human-Targeted Therapies in a Human Immune System
-
Sep 3, 2026, 16:35Mohsen Salimi: Non-Contrast Chest CT as a Biomarker for Mild-to-Moderate Anemia
-
Sep 3, 2026, 16:10Tanzeel Alamin Almahdi Gorashi: NLR as an Accessible Biomarker for Monitoring Pediatric Sickle Cell Anemia
-
Sep 3, 2026, 15:42Manuel De Jesus: Innovating Anemia Monitoring Through Biomedical Engineering and Digital Technology
-
Sep 3, 2026, 15:37Hadis Nabipoor: QICL2026 Highlights the Critical Importance of Transfusion Safety
-
Sep 3, 2026, 15:32Gopal Patidar: The ISBT Haemovigilance Working Party Sharing Knowledge and Promoting Best Practices
-
Sep 3, 2026, 15:24Bhalchandra Kawdikar: FDA Approves Rusfertide for Polycythemia Vera